Dr. Yuzuru Imai is an associate professor of Juntendo University Graduate School of Medicine
He
received
his PhD in biophysics from Kyoto University in 1999, and did a postdoctoral
fellowship
in Brain
Science Institute at RIKEN and at Stanford University from 1999 - 2007. He
started his
research as
a PI at Tohoku University in 2007 before moving to Juntendo university. His
main
research
area is neurodegenerative disorders, in particular pathogenic mechanism of
Parkinson’s
disease.
His current area of focus is understanding the role of Parkinson’s-associated
genes using
Drosophila,
mice, and iPS cells.
Professional
Training and Employment
1994 - 1996
Master course. Department of Animal Sciences, Graduate School of
Agriculture,
Kyoto University
1996 - 1999
Doctoral course. Department of Biophysics, Graduate School of Science,
Kyoto
University
1999 - 2001
Staff scientist. Brain Science Institute, RIKEN
2001 - 2004
Special postdoctoral fellow. RIKEN
2004 – 2007
Postdoctoral fellow. Department of Pathology, Stanford
University
School of Medicine
2007 – 2008
Associate professor. CRESS, Tohoku University
2008 – 2011
Associate professor. Institute of Development, Aging and Cancer, Tohoku
University
2011 –
present Associate professor, Juntendo University Graduate School of Medicine
Major
Research Interest
Mechanism
of selective neuronal death in Parkinson’s disease and other neuronal diseases
Professional
Membership/Other Appointments
Member,
Japan Neuroscience Society
Member, The
Molecular Biology Society of Japan
Member,
Society for Neuroscience
Member,
Societas Neurologica Japonica
Editorial
board member of Molecular Neurobiology in International Journal of Molecular
Sciences
(2019-)
Special
issue editor on "Animal Models of Parkinson's Disease and
Related Disorders" in
International
Journal of Molecular Sciences (2019-)
Lead guest
editor, Special issue on “Molecular Links between Mitochondrial Damage and
Parkinson's
Disease and Related Disorders” in Frontiers in Cell and Developmental
Biology
(2020-)
Editorial
Board Member, International Journal of Molecular Sciences (2020)
Associate
editor of Frontiers in Molecular and Cellular Pathology (2021-)
Review
editor of Frontiers in Neurogenetics (2022-)
Review
editor of Frontiers in Signaling (2022-)